Corporate Members

GlaxoSmithKline

GSK 2GSK,A KEY PLAYER IN R&D

GlaxoSmithKline is a science-led global healthcare company that researches and develops a broad range of innovative medicines and brands. Our products are used by millions of people around the world, helping them to do more, feel better and live longer

We have three primary areas of business in pharmaceuticals, vaccines and consumer healthcare. Our commercial success depends on creating innovative new products and making these accessible to as many people as possible. By achieving this, we will be able to grow our business and provide benefits to patients, consumers, society, our employees and our shareholders.

Our headquarters are based in the UK, and we have a wide geographical reach. We have offices in more than 115 countries, major research centres in the UK, USA, Spain, Belgium and China and an extensive manufacturing network with 87 sites globally.

Research is vitally important to the success of our business, and we spent just under £4 billion in 2012 in our search to develop new medicines, vaccines and innovating consumer products. We are one of the few healthcare companies researching medicines and vaccines for the World Health Organisation’s three priority diseases - HIV/AIDS, tuberculosis and malaria.

As a science-led global healthcare company we have the opportunity to improve the health and well-being of millions of people around the world.

Through investment in R&D and infrastructure, and through collaboration with other organisms, we are innovating to address currently unmet health needs. We are improving access to our products, irrespective of where people live or their ability to pay, and we are working to control or eliminate diseases affecting the world’s most vulnerable people.


 

 

SOCIETY

LAST NAME

FIRST NAME

ACTIVITIES

1

Bühlmann Laboratories

Buehlmann

Roland

Pharma/biotech

2

Galderma

Osman -Ponchet

Hanan

Pharma

3

GSK

Antoun

Zeina

Pharma

4

IPSEN

Thurieau

Christophe

Pharma

5

Novartis

Pallaud

Celine

Pharma

6

Roche Pharma

Funk

Christoph

Pharma

7

Sanofi Aventis

Sanderink

Gérard

Pharma

8

Teva

Grossman

Iris

Pharma

9

Laboratoires réunis

Weber

Bernard

Biotech

10

Thermo Fisher Scientific

Jacobs

Peter

Biotech

11

Luminex

Van Aarle

Pierre

Biotech

12

Randox

Lamont

John

Biotech

13

Roche Diagnostics

Jordan

Bruce

Biotech

14

Stabiligen

Siest

Jean-Pascal

Biotech

15

Eugenomic

Sabater

Juan

Biotech

16

Degruyter

Jahnke

Heike

IT

17

HMG Systems Engineering GmbH

Munoz-Galeano

Herna

IT

18

Genomatix

May

Klaus

IT

19

 Prahealthsciences

Purchase

Andrew

 Pharma

20

Translational Software                 

HACHAD             

RULE

Houda           

Don

IT                      

21

Abomics

HUISKALA

Oskari

IT

 

 

 

Documents
ESPT Corporate Members Meeting, Santorini, Greece (September 26th, 2014)
ESPT Corporate Members Meeting, Lisbon, Portugal (September 28th, 2013)
ESPT Corporate Members meeting, Santorini, Greece (September 30th and October 1st 2012)